Information Provided By:
Fly News Breaks for November 13, 2015
MDT, ABT
Nov 13, 2015 | 06:26 EDT
Goldman Sachs analyst David Roman downgraded Abbott (ABT) to Neutral citing a more balanced risk/reward following the recent rebound in shares. The analyst sees greater upside elsewhere in the space and upgraded Medtronic (MDT) to Conviction Buy. He keeps a $48 price target for shares of Abbott.
News For ABT;MDT From the Last 2 Days
There are no results for your query ABT;MDT